Peter Kotsonis, PhD

InstitutionUniversity of California San Francisco
DepartmentInnovation Ventures
Address600 16th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Culshaw AJ, Bevan S, Christiansen M, Copp P, Davis A, Davis C, Dyson A, Dziadulewicz EK, Edwards L, Eggelte H, Fox A, Gentry C, Groarke A, Hallett A, Hart TW, Hughes GA, Knights S, Kotsonis P, Lee W, Lyothier I, McBryde A, McIntyre P, Paloumbis G, Panesar M, Patel S, Seiler MP, Yaqoob M, Zimmermann K. Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. J Med Chem. 2006 Jan 26; 49(2):471-4. PMID: 16420034.
      View in: PubMed
    2. Matter H, Kumar HS, Fedorov R, Frey A, Kotsonis P, Hartmann E, Fröhlich LG, Reif A, Pfleiderer W, Scheurer P, Ghosh DK, Schlichting I, Schmidt HH. Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases. J Med Chem. 2005 Jul 28; 48(15):4783-92. PMID: 16033258.
      View in: PubMed
    3. Scotland RS, Chauhan S, Davis C, De Felipe C, Hunt S, Kabir J, Kotsonis P, Oh U, Ahluwalia A. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res. 2004 Nov 12; 95(10):1027-34. PMID: 15499026.
      View in: PubMed
    4. Matter H, Kotsonis P. Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents. Med Res Rev. 2004 Sep; 24(5):662-84. PMID: 15224385.
      View in: PubMed
    5. Paclet MH, Davis C, Kotsonis P, Godovac-Zimmermann J, Segal AW, Dekker LV. N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates. Biochem J. 2004 Jan 15; 377(Pt 2):469-77. PMID: 14556648; PMCID: PMC1223878.
    6. Savidge J, Davis C, Shah K, Colley S, Phillips E, Ranasinghe S, Winter J, Kotsonis P, Rang H, McIntyre P. Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology. 2002 Sep; 43(3):450-6. PMID: 12243775.
      View in: PubMed
    7. Matter H, Kotsonis P, Klingler O, Strobel H, Fröhlich LG, Frey A, Pfleiderer W, Schmidt HH. Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors. J Med Chem. 2002 Jul 04; 45(14):2923-41. PMID: 12086480.
      View in: PubMed
    8. Iannazzo L, Kotsonis P, Majewski H. .Life Sci. Modulation of acetylcholine release from mouse cortex by protein kinase C: dependence on stimulation intensity. . 2000; 1(67):31-8.
    9. Murphy TV, Prountzos C, Kotsonis P, Iannazzo L, Majewski H. .Eur J Pharmacol. Structural determinants of phorbol ester binding in synaptosomes: pharmacokinetics and pharmacodynamics. . 1999; 1(381):77-84.
    10. Iannazzo L, Kotsonis P, Majewski H. .Br J Pharmacol. The structural requirements for phorbol esters to enhance serotonin and acetylcholine release from rat brain cortex. . 1999; 5(127):1177-89.
    Peter's Networks
    Derived automatically from this person's publications.
    Related Authors
    People who share related concepts with this person.